CLONEGENE LLC Information

Clonegene develops antibodies and enzymes of utility in research and clinical applications. Many of these reagents are available to be licensed or distributed. We are currently focusing on novel antibodies useful in the therapy of Small Cell Lung Cancer.

Website	http://www.clonegene.com/clonegene.html
Revenue	$4 million
Employees	1 (0 on RocketReach)
Founded	2001
Address	146 Kenyon St, Hartford, Connecticut 06105, US
Phone	+1 860-679-7627
Technologies	PHP , OpenResty , PayPal +4 more (view full list)
Industry	Biotechnology Research, Business Services General, Business Services
Keywords	Monoclonal Antibodies, Therapeutic Antibodies, Cancer Diagnostics, Cellular Therapy, Tumor Targeting, Precision Medicine, Immunotherapy, Molecular Diagnostics, Protein Therapeutics, Biopharma, Antibody Engineering, Pharmaceutical Research, Biotechnology, Clinical Research, Cancer Research, Cancer Treatment, Drug Development, Lab Reagents, Oncology, Biotechnology Research
Competitors	Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, GenScript, New England Biolabs, Sangamo Therapeutics, Inc., Enzo Life Sciences, GeneCopoeia +37 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies